R&D Spotlight: Oncology
Technical Update: Science & Innovationthe New Frontier
R&D Spotlight: Infectious Diseases
Technical Update: Quantum Computing & Life Sciences
Lunch & Networking
R&D Spotlight: Medtech
Nick Skaer
  • Nick Skaer (CEO of Orthox Limited)

    Nick Skaer

    CEO of Orthox Limited
R&D Spotlight: Microbiome
R&D Spotlight: Rare Diseases
R&D Spotlight: Neuroscience
R&D Spotlight: Oncology
Technical Update: Tageted Protein DegradationProgress, Direction and Prospects
Lunch & Networking
R&D Spotlight: Inflammatory Disease
R&D Spotlight: Cell & Gene Therapy
Carolyn Porter
  • Carolyn Porter (CEO of CytoSeek)

    Carolyn Porter

    CEO of CytoSeek

BioTrinity Panels, Interviews & Keynotes

 

We aim to deliver a well-rounded programme of presentations, discussions, and debate around a variety of subject matters prevalent in the life sciences industry today. We include a mix of scientific focused topics, which either address the latest innovation and research, or matters that are popular and much talked about in the current mainstream landscape, along with pertinent updates on the financing and investment landscapes, as well as regulatory and legislative updates from leading voices and decision makers.

 

We cover a lot of ground, and the range is broad, but we aim to support our delegates by delivering a programme that is digestible, useful, and thought-provoking.


Each R&D spotlight will include 5 x 10 minute company presentations from the most innovative companies working in; Oncology, Infectious Diseases, Microbiome, Rare Diseases, Medtech, Neuroscience, Inflammatory Disease and Cell and Gene Therapy. If you are a company seeking Series A investment or to partner assets, BioTrinity is for you! Contact events@obn.org.uk


Detailed below is an outline of all of the sessions, if you have any queries then please email events@obn.org.uk